This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Intellectual Property

Newsletter RSS

middle aged balding white man with glasses and a suit and tie testifying in front of a committee, with a small crowd assembled behind him

USPTO chief Squires' planned party sparks ethics concerns

Novartis logo

Novartis reputation fails to block rival drugmaker's 'Devatis' EU trademarks

Samsung defeats Maxell patent UPC case over Galaxy content-sharing tech

Insight View More

Canada uses global IP system to commercialize inventions abroad, CIPO chief says September 28, 2026 | Steve Scherer

Canada’s use of global patent and trademark systems helps domestic inventions reach foreign markets, where much commercialization occurs, said Canadian Intellectual Property Office chief Konstantinos Georgaras... (more story)

Squires says USPTO’s superior intelligence tools already a success September 28, 2026 | Nick Robertson

US Patent and Trademark Office Director John Squires embraced the Trump-led push to shift artificial intelligence terminology to “SI,” or super intelligence, telling conferencegoers in Toronto on Monday that h... (more story)

UPC mediation hub seeks input on global FRAND dispute guidelines September 28, 2026 | Inbar Preiss

The Unified Patent Court’s mediation and arbitration center is seeking input from experts and industry on developing guidelines on handling disputes over fair, reasonable and non-discriminatory, or FRAND, lice... (more story)

USPTO chief Squires' planned party sparks ethics concerns September 25, 2026 | Nick Robertson

A celebration backed by industry groups for US Patent and Trademark Office Director John Squires has been organized by office staff at Squires’ direction, MLex understands, raising ethics concerns among curren... (more story)

Challenge to supplementary protection on Takeda ADHD drug falls flat in UK September 25, 2026 | Melissa Ritti

A supplementary protection certificate which provided protection after patent expiry for the active ingredient in Takeda’s ADHD drug Elvanse in the UK was deemed valid there on Thursday. The ruling marks a blo... (more story)

Standard implementers warn of growing patent abuse: 'Consumer suffering is here' September 25, 2026 | Nick Robertson

Costly infringement suits over standard-essential patents are reaching more industries and degrading the meaning of fair, reasonable and nondiscriminatory licensing negotiations, in a trend exacerbated by a ri... (more story)

Value Drug plausibly alleges Alkermes duped USPTO, judge says in antitrust suit September 24, 2026 | Chris May

Value Drug has plausibly alleged global biopharmaceutical company Alkermes violated federal antitrust law by protecting its monopoly on the drug naltrexone through material misrepresentations to the US Patent ... (more story)

Collision appeal raises stakes for future of patent injunctions September 24, 2026 | Nick Robertson

Opponents of restoring a presumption in favor of patent injunctions warned Wednesday that Collision Communications’ appeal against Samsung could reopen debate over the standard set by the US Supreme Court in e... (more story)

Comment View More

Platforms fear erosion of liability protection in draft European Product Act September 25, 2026 | Matthew Newman

European online marketplaces fear the draft European Product Act could make them frontline product-compliance enforcers, raising costs and legal exposure through new checks before products are listed. Platform... (more story)

Proof gap in UK Section 74A software patent disputes spotlighted in IPO opinion September 25, 2026 | Melissa Ritti

A finding this week that an artificial intelligence-powered content-moderation system was not shown to infringe a Lighthouse Technologies patent underscores the evidentiary limitations of the UK Intellectual P... (more story)

Rare USITC fast-track proceeding tests GG Technologies’ US investment September 24, 2026 | Steve Scherer

GG Technologies’ NameDrop patent case against Apple is well suited to the US International Trade Commission’s rarely used 100-day procedure, four lawyers told MLex, because it presents a narrow question about ... (more story)

New Thomas Pink womenswear lines strain ‘PINK’ pact with Victoria’s Secret September 21, 2026 | Melissa Ritti

A 2015 agreement allowed Victoria’s Secret and Thomas Pink Ltd. to end their global fight over “PINK” and coexist in different commercial terrain. Now, after the London shirtmaker’s assets have changed hands t... (more story)

How far can a software trademark reach? Autonomous cars put EU rules to the test September 21, 2026 | Inbar Preiss

A dispute over Deutsche Bahn's Kira trademark for autonomous-driving software and vehicles has prompted the European Union Intellectual Property Office to ask its top appeal board whether “computer software” i... (more story)

Via LA targets one-stop shop for AI data center patent licenses, president says September 18, 2026 | Steve Scherer

Via LA has launched its DRAM data center patent pool with three of the field’s top 15 largest patent holders and is negotiating with most of the rest, President Kevin Mack told MLex. A second group of new memb... (more story)

OpenAI’s failed UK trademark challenge deepens doubts over ‘GPT’ protectability September 18, 2026 | Melissa Ritti

The UK Intellectual Property Office recently invalidated UK trademark rights in “GPT” and “ChatGPT” while rejecting OpenAI’s bid to block ChainGPT LLC from registering its name there. The decision gives UK app... (more story)

India's life-sciences patent guidelines promise clarity, but consistency will be the test September 18, 2026 | Freny Patel

India's draft life-sciences patent guidelines could improve predictability without easing patentability standards, but their impact will depend on consistent examination and applying existing jurisprudence to ... (more story)